Call us : 1800 103 7100
Mail us : info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

PROMUS Element(TM) Stent Demonstrates Excellent Long-Term Safety and … – MarketWatch (press release)

May 18, 2012Immunosuppressive Drugsadmin

PROMUS Element(TM) Stent Demonstrates Excellent Long-Term Safety and ...
MarketWatch (press release)
PROMUS is a private-labeled XIENCE V everolimus-eluting stent system manufactured by Abbott and distributed by Boston Scientific. The PLATINUM Small Vessel study is a prospective, multicenter, single-arm, subtrial of the PLATINUM clinical program ...
Boston Scientific Reports 2-yr Results From PLATINUM Small Vessel StudyRTT News

all 6 news articles »

Post navigation

← Cardio3 BioSciences Has Been Selected to Present C3BS-CQR-1 Trial Data in Late … – MarketWatch (press release) Organ-donor drive persuades 5000 to pledge online – Winnipeg Free Press →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Hosted and managed by www.medindindia.net